🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07781748
Starting soon Not applicable

Improving Quality of Informal Care for People With Schizophrenia

NCT07781748 · tracked via the Priya Life Science China tracker
Sponsor
Chinese University of Hong Kong
Phase
Not applicable
Started
2027-07-01
Last updated
2026-08-25

Condition(s) studied

Schizophrenia

Investigational drug(s) / intervention(s)

Dyadic Multicomponent Intervention (DMI)Dyadic Benefit-Finding Intervention (DBFI)

Dyadic Multicomponent Intervention (DMI): An 8-week program delivered face-to-face to each person-with-schizophrenia and informal-caregiver dyad together, one 120-minute session per week. Each session combines three components: Dyadic Benefit-Finding Intervention (psychoeducation and positive reappraisal, 60 minutes), Dyadic Exercise Intervention (guided mind-body exercise such as Qigong, Tai Chi, or Baduanjin, 30 minutes), and Dyadic Spiritual Training (mindfulness and life review, 30 minutes). Content is tailored to each dyad and delivered by a trained team of psychiatrists, exercise physiologists, and social workers.

Dyadic Benefit-Finding Intervention (DBFI): An 8-week program delivered face-to-face to each person-with-schizophrenia and informal-caregiver dyad together, one 60-minute session per week. It provides psychoeducation about schizophrenia and caregiving, benefit-finding diaries, and guided practice in positive reappraisal, helping dyads recognize positive experiences and coping resources. This arm does not include the exercise or spiritual training components. It is delivered by a trained team of psychiatrists and social workers.

Study summary

The goal of this clinical trial is to learn if a new support program can improve the quality of informal care for people with schizophrenia in rural China. Informal care means the unpaid care given by family members. Quality of care involves both the care that family members give and the care that people with schizophrenia receive. The study also looks at whether the program improves the health and well-being of both groups.

The main questions it aims to answer are:

1. Does the support program improve the quality of care that family caregivers provide and that people with schizophrenia receive?
2. Does the program improve the health and well-being of people with schizophrenia and their caregivers?

Researchers will compare three groups to see which works best:

1. A full support program with health education, physical activities, and spiritual activities
2. A program with health education only
3. A control group that receives only routine care

Each person with schizophrenia takes part together with their family caregiver as a pair. Participants will:

1. Take part in an 8-week program in their community
2. Answer survey questions three times: before the program, right after it ends, and 6 months later
3. Some participants will also join interviews to share their experiences

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Persons with schizophrenia (PwS): Aged 18 years or older; Diagnosed with schizophrenia by a psychiatrist, with the diagnosis validated using SCID-5; Have not previously participated in any intervention studies; Functional and able to communicate and take part in group activities; Able to provide written informed consent * Informal caregivers (ICGs): Aged 18 years or older; Provide unpaid care to a person with schizophrenia; Have not previously participated in any intervention studies; Able to provide written informed consent Exclusion Criteria: * Persons with schizophrenia (PwS): Likely to engage in risky behaviors (e.g., suicide or violence), or a history of alcohol or substance abuse; Identified by professionals as unsuitable to participate (e.g., unable to sustain meaningful conversation); Having other schizophrenia spectrum disorders or co-existing neurodevelopmental disorders * Informal caregivers (ICGs): Likely to engage in risky behaviors (e.g., suicide or violence); Identified by professionals as unsuitable to participate (e.g., having a mental illness or unable to understand instructions)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xinjin Second Peope's Hospital Chengdu Sichuan

More Chinese University of Hong Kong trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07781748 on ClinicalTrials.gov ↗ ← All trials in China